Oxford Nanopore at AMP 2025
The Association for Molecular Pathology (AMP) Annual Meeting & Expo features more than 200 exhibiting companies, 60 educational sessions, nearly 400 poster presentations, and 3,000+ attendees/exhibitors.
Oxford Nanopore will be located at Booth 1510, and will host 2 Corporate Workshops on Wednesday, November 12 at 12:00 pm and 2:00 pm EST. Exhibits will be open from November 13 to November 15.
)
Corporate Workshop 1
Oxford Nanopore Technologies: Revolutionizing Oncology with Comprehensive Multiomic Sequencing Solutions
Join us on Corporate Workshop Day to explore how Oxford Nanopore’s multiomic sequencing solutions are transforming oncology. Learn how real-time, any-read length sequencing can enable comprehensive oncology assays. Discover how a single assay can detect SNVs, indels, structural variants, copy number changes, and methylation — with native DNA or RNA sequencing. Whether leveraging adaptive sampling for hereditary cancer panels or direct DNA sequencing for tumor methylation classification, Oxford Nanopore sequencing empowers streamlined, scalable insights across the cancer continuum.
Date: Wednesday, November 12, 2025
Time: 12:00 pm-12:50 pm EST
Location: Room 155, Level 1, Boston Convention and Exhibition Center
Speakers
Updates from Oxford Nanopore
Ellie Juarez, Oxford Nanopore Technologies
...
)
Rapid comprehensive molecular profiling of CNS tumors
Areeba Patel, PhD, German Cancer Research Center, Heidelberg
...
)
Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia
Francisco Marchi, PhD, ALMA Genomics Inc
Francisco was born and raised in Brazil and is a cancer survivor dedicated to advancing precision me...
Corporate Workshop 2
Oxford Nanopore Technologies: Unlocking hidden genomic regions for rare disease research
Join us on Corporate Workshop Day to explore how Oxford Nanopore's unrestricted read length sequencing technology is transforming rare disease research and human genome analysis. Discover how Oxford Nanopore sequencing captures comprehensive genomic variation—including structural variants, repeat expansions, and epigenetic modifications. Learn how the latest applications using Oxford Nanopore long-read technology are accessing previously difficult-to-sequence genomic regions to advance rare disease research and unlock new insights into human genetic variation.
Date: Wednesday, November 12, 2025
Time: 02:00 pm-02:50 pm PST
Location: Room 156AB, Level 1, Boston Convention and Exhibition Center
Speakers
)
Updates from Oxford Nanopore
Alex Lindell, Oxford Nanopore Technologies
Alex Lindell is Senior Director of Clinical Solutions at Oxford Nanopore Technologies, where he lead...
)
Long-Range PCR Meets Long-Read Sequencing to Resolve Challenging ACMG Tier 3 Carrier Screening Genes
Brian Haynes, CSO, Asuragen, a Bio-Techne Brand
...
)
Oxford Nanopore-Based Structural and Epigenetic Profiling of D4Z4 Arrays in FSHD
Dr. Scott Hickey, Oxford Nanopore Technologies
Scott Hickey is Senior Director of Commercial Applications at Oxford Nanopore, where he leads global...
